Drug Trial Radar · NCT07857473
A Study to Investigate the Safety and Efficacy of TE-8105 in Overweight or Obesity Participants
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
204
Planned (sponsor's estimate)
Start
Oct 2026
Primary completion
Feb 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- Immunwork, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2b, randomized, double-blind, placebo-controlled, multiple ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of TE-8105 in adults with overweight or obesity, with or without weight-related health conditions. Participants in this study will receive subcutaneous (under the skin) injections of either TE-8105 or placebo for 25 weeks. The total study duration, including screening and follow-up visits, is approximately 8 months.
Conditions
- Overweight and Obesity
Interventions
TE-8105 MAD Cohort 1Drug
Administered via SC injection.
TE-8105 MAD Cohort 2Drug
Administered via SC injection.
TE-8105 MAD Cohort 3Drug
Administered via SC injection.
PlaceboDrug
Administered via SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events, including treatment-related adverse events.Time frame: up to 31 weeks after 1st dosing
- Changes from baseline in clinical laboratory assessments, physical examination findings, vital signs, and electrocardiogram (ECG) values.Time frame: up to 31 weeks after 1st dosing
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Canopy Clinical Inner West
Leichhardt, New South Wales, Australia
Canopy Clinical Western Sydney
Penrith, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.